4/A: Arteris Director Antonio J. Viana Amends Form 4 to Correctly Report Share Sales and Holdings

Antonio J. Viana, a director at Arteris, Inc., filed an amended Form 4 to correct the number of shares sold on June 7, 2024, and the total shares beneficially owned following the transaction.

Summary

• Antonio J. Viana, a director of Arteris, Inc., filed an amendment to a previously submitted Form 4.
• The amendment corrects the number of shares of common stock sold on June 7, 2024, and the total number of shares beneficially owned after the transaction.
• The original filing inadvertently overstated the number of shares sold.
• On May 30, 2024, Viana transferred 2,781 shares to the Viana Family Trust and the Viana Family Trust transferred 2,781 shares to Viana.
• On June 6, 2024, Viana transferred 29,027 shares to the Viana Family Trust and the Viana Family Trust transferred 29,027 shares to Viana.
• On June 7, 2024, Viana sold 26,191 shares at a weighted average price of $7.8545 per share, with prices ranging from $7.69 to $8.08.
• Following these transactions, Viana directly owns 19,288 shares and indirectly owns 204,367 shares through the Viana Family Trust.
• The sale on June 7, 2024, was executed under a 10b5-1 trading plan adopted on December 5, 2022.

Sentiment

Score: 5

Explanation: The sentiment is neutral. It's a correction of a previous filing and a routine disclosure of share sales under a pre-arranged trading plan. While insider sales can sometimes be viewed negatively, the existence of the 10b5-1 plan mitigates this concern.

Industry Context

This filing is a routine disclosure related to insider trading activities, which are common in publicly traded companies. The use of a 10b5-1 trading plan suggests a pre-planned and compliant approach to selling shares.

Comparison to Industry Standards

• Form 4 filings are standard practice for corporate insiders and are comparable across all publicly traded companies.
• The use of a 10b5-1 trading plan is a common method employed by executives to avoid accusations of insider trading, aligning with industry best practices.
• The reported weighted average sale price of $7.8545 is specific to Arteris's stock performance on the transaction date and would be compared against its peers in the semiconductor or technology industry to assess relative valuation.

Related Party Transactions

• Shares were transferred to the Viana Family Trust, for which Antonio J. Viana is the trustee.

Stakeholder Impact

• The corrected information ensures transparency for shareholders regarding insider transactions.
• The sale of shares by a director may have a minor impact on investor sentiment.

Key Dates